Evaluation of intravenous parecoxib for the relief of acute post-surgical pain

Expert Opinion on Investigational Drugs

Volumn 9, Issue 11, 2000, Pages 2717-2723

  Jain, K K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

Acute pain; COX; COX 2 inhibitors; NSAIDs; Parecoxib; Post surgical postoperative pain; Valdecoxib

Indexed keywords

ACETYLSALICYLIC ACID; ADL 100101; ADL 21294; ANALGESIC AGENT; ARACHIDONIC ACID; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; CARRAGEENAN; CGX 1160; CLONIDINE; CONTULAKIN G; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; KETAMINE; KETOPROFEN; KETOROLAC; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA CONOTOXIN MVIIA; OPIATE AGONIST; PARECOXIB; PHOSPHOLIPID; PLACEBO; REMIFENTANIL; UNCLASSIFIED DRUG; VALDECOXIB; VANILLOID RECEPTOR 1 ANTAGONIST; WPS 004;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG APPROVAL; DRUG COST; DRUG FORMULATION; DRUG MARKETING; DRUG METABOLISM; DRUG POTENCY; DRUG TRANSFORMATION; DUODENUM ULCER; DYSPEPSIA; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; NEUROTOXICITY; NONHUMAN; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; RAT; STOMACH ULCER; VOMITING;

EID: 0033762410     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.11.2717     Document Type: Article

References (19)

1. N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl] sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration
2. Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system
3. Pain therapeutics: Re-evaluation of strategies
4. Celecoxib: A review of its use in osteoarthritis, rheumatoid arthritis and acute pain
5. Safety and feasibility of continuous infusion of remifentanil in the neurosurgical intensive care
6. Pre-emptive analgesia by iv. low-dose ketamine and epidural morphine in gastrectomy: A randomized double-blind study
7. An evaluation of intrathecal ziconotide for the treatment of chronic pain
8. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
9. 4-[5-methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2
10. Correlation of pharmacokinetics (PK) with onset and duration of analgesia of im. Doses of parecoxib in postoperative dental pain
11. Pharmacokinetic and efficacy evaluation of iv. Parecoxib in a postsurgical dental pain model
12. An endoscopic study of the gastroduodenal effects of SC-69142A, a parenteral COX-2-specific inhibitor in the elderly
13. A guide to drug evaluation for chronic pain
14. Platelet dysfunction after iv. Ketorolac or propacetamol
15. Use of COX-2 specific inhibitors in operative and nonoperative management of patients with arthritis
16. Wound collagen deposition in rats: Effects of an NO-NSAID and a selective COX-2 inhibitor
17. Cyclooxygenase-2 enzyme inhibitors: Place in therapy
18. COX-2 selective nonsteroidal anti-inflammatory drugs: Do they really offer any advantages?